Stuart A. Kingsley

2016 - Medicines

In 2016, Stuart A. Kingsley earned a total compensation of $5.7M as President and Chief Operating Officer at Medicines.

Compensation breakdown

Non-Equity Incentive Plan$255,957
Option Awards$5,000,020
Salary$406,250
Other$61,578
Total$5,723,805

Kingsley received $5M in option awards, accounting for 87% of the total pay in 2016.

Kingsley also received $256K in non-equity incentive plan, $406.3K in salary and $61.6K in other compensation.

Rankings

In 2016, Stuart A. Kingsley's compensation ranked 1,317th out of 14,075 executives tracked by ExecPay. In other words, Kingsley earned more than 90.6% of executives.

ClassificationRankingPercentile
All
1,317
out of 14,075
91st
Division
Manufacturing
441
out of 5,489
92nd
Major group
Chemicals And Allied Products
118
out of 1,895
94th
Industry group
Drugs
80
out of 1,538
95th
Industry
Pharmaceutical Preparations
65
out of 1,176
95th
Source: SEC filing on April 26, 2017.

Kingsley's colleagues

We found four more compensation records of executives who worked with Stuart A. Kingsley at Medicines in 2016.

2016

Clive Meanwell

Medicines

Chief Executive Officer

2016

Christopher Cox

Medicines

Chief Corporate Development Officer

2016

William O'Connor

Medicines

Chief Financial Officer

2016

Stephen Rodin

Medicines

General Counsel

News

In-depth

You may also like